<?xml version='1.0' encoding='utf-8'?>
<document id="26114620"><sentence text="Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy."><entity charOffset="43-54" id="DDI-PubMed.26114620.s1.e0" text="cannabidiol" /></sentence><sentence text="Under an expanded access investigational new drug (IND) trial, cannabidiol (CBD) is being studied as a possible adjuvant treatment of refractory epilepsy in children"><entity charOffset="63-74" id="DDI-PubMed.26114620.s2.e0" text="cannabidiol" /><entity charOffset="76-79" id="DDI-PubMed.26114620.s2.e1" text="CBD" /><pair ddi="false" e1="DDI-PubMed.26114620.s2.e0" e2="DDI-PubMed.26114620.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s2.e0" e2="DDI-PubMed.26114620.s2.e1" /></sentence><sentence text=" Of the 25 subjects in the trial, 13 were being treated with clobazam (CLB)"><entity charOffset="61-69" id="DDI-PubMed.26114620.s3.e0" text="clobazam" /></sentence><sentence text=" Because CLB and CBD are both metabolized in the cytochrome P450 (CYP) pathway, we predicted a drug-drug interaction, which we evaluate in this article"><entity charOffset="17-24" id="DDI-PubMed.26114620.s4.e0" text="CBD" /></sentence><sentence text="" /><sentence text="Thirteen subjects with refractory epilepsy concomitantly taking CLB and CBD under IND 119876 were included in this study"><entity charOffset="72-75" id="DDI-PubMed.26114620.s6.e0" text="CBD" /></sentence><sentence text=" Demographic information was collected for each subject including age, sex, and etiology of seizures, as well as concomitant antiepileptic drugs (AEDs)" /><sentence text=" CLB, N-desmethylclobazam (norclobazam; nCLB), and CBD levels were measured over the course of CBD treatment"><entity charOffset="1-4" id="DDI-PubMed.26114620.s8.e0" text="CLB" /><entity charOffset="6-25" id="DDI-PubMed.26114620.s8.e1" text="N-desmethylclobazam" /><entity charOffset="27-38" id="DDI-PubMed.26114620.s8.e2" text="norclobazam" /><entity charOffset="40-44" id="DDI-PubMed.26114620.s8.e3" text="nCLB" /><entity charOffset="51-54" id="DDI-PubMed.26114620.s8.e4" text="CBD" /><entity charOffset="95-98" id="DDI-PubMed.26114620.s8.e5" text="CBD" /><entity charOffset="41-43" id="DDI-PubMed.26114620.s8.e6" text="CLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e6" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e0" e2="DDI-PubMed.26114620.s8.e5" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e1" e2="DDI-PubMed.26114620.s8.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e1" e2="DDI-PubMed.26114620.s8.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e1" e2="DDI-PubMed.26114620.s8.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e1" e2="DDI-PubMed.26114620.s8.e6" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e1" e2="DDI-PubMed.26114620.s8.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e1" e2="DDI-PubMed.26114620.s8.e5" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e2" e2="DDI-PubMed.26114620.s8.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e2" e2="DDI-PubMed.26114620.s8.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e2" e2="DDI-PubMed.26114620.s8.e6" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e2" e2="DDI-PubMed.26114620.s8.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e2" e2="DDI-PubMed.26114620.s8.e5" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e3" e2="DDI-PubMed.26114620.s8.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e3" e2="DDI-PubMed.26114620.s8.e6" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e3" e2="DDI-PubMed.26114620.s8.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e3" e2="DDI-PubMed.26114620.s8.e5" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e6" e2="DDI-PubMed.26114620.s8.e6" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e6" e2="DDI-PubMed.26114620.s8.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e6" e2="DDI-PubMed.26114620.s8.e5" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e4" e2="DDI-PubMed.26114620.s8.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s8.e4" e2="DDI-PubMed.26114620.s8.e5" /></sentence><sentence text=" CLB doses were recorded at baseline and at weeks 4 and 8 of CBD treatment"><entity charOffset="61-64" id="DDI-PubMed.26114620.s9.e0" text="CBD" /><entity charOffset="1-3" id="DDI-PubMed.26114620.s9.e1" text="CLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s9.e1" e2="DDI-PubMed.26114620.s9.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s9.e1" e2="DDI-PubMed.26114620.s9.e0" /></sentence><sentence text=" Side effects were monitored" /><sentence text="" /><sentence text="We report elevated CLB and nCLB levels in these subjects"><entity charOffset="19-21" id="DDI-PubMed.26114620.s12.e0" text="CLB" /><entity charOffset="28-30" id="DDI-PubMed.26114620.s12.e1" text="CLB" /><entity charOffset="27-29" id="DDI-PubMed.26114620.s12.e2" text="nCLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s12.e0" e2="DDI-PubMed.26114620.s12.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s12.e0" e2="DDI-PubMed.26114620.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s12.e0" e2="DDI-PubMed.26114620.s12.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s12.e2" e2="DDI-PubMed.26114620.s12.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s12.e2" e2="DDI-PubMed.26114620.s12.e1" /></sentence><sentence text=" The mean (± standard deviation [SD]) increase in CLB levels was 60 ± 80% (95% confidence interval (CI) [-2-91%] at 4 weeks); the mean increase in nCLB levels was 500 ± 300% (95% CI [+90-610%] at 4 weeks)"><entity charOffset="50-53" id="DDI-PubMed.26114620.s13.e0" text="CLB" /><entity charOffset="148-151" id="DDI-PubMed.26114620.s13.e1" text="CLB" /><entity charOffset="147-150" id="DDI-PubMed.26114620.s13.e2" text="nCLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s13.e0" e2="DDI-PubMed.26114620.s13.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s13.e0" e2="DDI-PubMed.26114620.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s13.e0" e2="DDI-PubMed.26114620.s13.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s13.e2" e2="DDI-PubMed.26114620.s13.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s13.e2" e2="DDI-PubMed.26114620.s13.e1" /></sentence><sentence text=" Nine of 13 subjects had a &gt;50% decrease in seizures, corresponding to a responder rate of 70%" /><sentence text=" The increased CLB and nCLB levels and decreases in seizure frequency occurred even though, over the course of CBD treatment, CLB doses were reduced for 10 (77%) of the 13 subjects"><entity charOffset="111-114" id="DDI-PubMed.26114620.s15.e0" text="CBD" /><entity charOffset="15-17" id="DDI-PubMed.26114620.s15.e1" text="CLB" /><entity charOffset="24-26" id="DDI-PubMed.26114620.s15.e2" text="CLB" /><entity charOffset="126-128" id="DDI-PubMed.26114620.s15.e3" text="CLB" /><entity charOffset="23-25" id="DDI-PubMed.26114620.s15.e4" text="nCLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e1" e2="DDI-PubMed.26114620.s15.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e1" e2="DDI-PubMed.26114620.s15.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e1" e2="DDI-PubMed.26114620.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e1" e2="DDI-PubMed.26114620.s15.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e1" e2="DDI-PubMed.26114620.s15.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e4" e2="DDI-PubMed.26114620.s15.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e4" e2="DDI-PubMed.26114620.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e4" e2="DDI-PubMed.26114620.s15.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e4" e2="DDI-PubMed.26114620.s15.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e2" e2="DDI-PubMed.26114620.s15.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e2" e2="DDI-PubMed.26114620.s15.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e2" e2="DDI-PubMed.26114620.s15.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e0" e2="DDI-PubMed.26114620.s15.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s15.e0" e2="DDI-PubMed.26114620.s15.e3" /></sentence><sentence text=" Side effects were reported in 10 (77%) of the 13 subjects, but were alleviated with CLB dose reduction"><entity charOffset="85-88" id="DDI-PubMed.26114620.s16.e0" text="CLB" /></sentence><sentence text="" /><sentence text="Monitoring of CLB and nCLB levels is necessary for clinical care of patients concomitantly on CLB and CBD"><entity charOffset="102-104" id="DDI-PubMed.26114620.s18.e0" text="CBD" /><entity charOffset="14-16" id="DDI-PubMed.26114620.s18.e1" text="CLB" /><entity charOffset="23-25" id="DDI-PubMed.26114620.s18.e2" text="CLB" /><entity charOffset="94-96" id="DDI-PubMed.26114620.s18.e3" text="CLB" /><entity charOffset="22-24" id="DDI-PubMed.26114620.s18.e4" text="nCLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e1" e2="DDI-PubMed.26114620.s18.e1" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e1" e2="DDI-PubMed.26114620.s18.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e1" e2="DDI-PubMed.26114620.s18.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e1" e2="DDI-PubMed.26114620.s18.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e1" e2="DDI-PubMed.26114620.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e4" e2="DDI-PubMed.26114620.s18.e4" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e4" e2="DDI-PubMed.26114620.s18.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e4" e2="DDI-PubMed.26114620.s18.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e4" e2="DDI-PubMed.26114620.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e2" e2="DDI-PubMed.26114620.s18.e2" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e2" e2="DDI-PubMed.26114620.s18.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e2" e2="DDI-PubMed.26114620.s18.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e3" e2="DDI-PubMed.26114620.s18.e3" /><pair ddi="false" e1="DDI-PubMed.26114620.s18.e3" e2="DDI-PubMed.26114620.s18.e0" /></sentence><sentence text=" Nonetheless, CBD is a safe and effective treatment of refractory epilepsy in patients receiving CLB treatment"><entity charOffset="14-17" id="DDI-PubMed.26114620.s19.e0" text="CBD" /><entity charOffset="97-99" id="DDI-PubMed.26114620.s19.e1" text="CLB" /><pair ddi="false" e1="DDI-PubMed.26114620.s19.e0" e2="DDI-PubMed.26114620.s19.e0" /><pair ddi="false" e1="DDI-PubMed.26114620.s19.e0" e2="DDI-PubMed.26114620.s19.e1" /></sentence><sentence text="" /></document>